Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA 2 DS 2 -VASc Risk Factor Be Anticoagulated?-Reference-Cited by-同舟云学术

Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA 2 DS 2 -VASc Risk Factor Be Anticoagulated?

Published:2016-07 Issue:7 Volume:47 Page:1831-1836
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Fauchier Laurent¹,Clementy Nicolas¹,Bisson Arnaud¹,Ivanes Fabrice¹,Angoulvant Denis¹,Babuty Dominique¹,Lip Gregory Y.H.¹

Affiliation:

1. From the Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France (L.F., N.C., A.B., F.I., D.A., D.B.); University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (G.Y.H.L.); and Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark (G.Y.H.L.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference15 articles.

1. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

2. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

3. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation

4. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

5. National Clinical Guideline Centre (UK). Atrial Fibrillation: The Management of Atrial Fibrillation [Internet]. London United Kingdom: National Institute for Health and Care Excellence (UK); 2014. http://www.ncbi.nlm.nih.gov/books/NBK248059/. Accessed April 14 2016.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial fibrillation: stroke prevention;The Lancet Regional Health - Europe;2024-02

2. Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study;European Heart Journal;2023-11-23

3. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation at low risk of stroke in japan: a retrospective cohort study;European Heart Journal - Cardiovascular Pharmacotherapy;2023-10-19

4. Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Low Stroke Risk;The American Journal of Cardiology;2023-10

5. Determinants of Atrial Fibrillation Progression and Its Influence on Overall Mortality in a Cohort of Patients From South India;Cureus;2023-09-12